登录

Meio CadiNav Medical Completes Pre-Series A Financing

Mailman 2021-08-23 16:34

梅奥心磁
企业数据由 动脉橙 提供支持
心脏介入手术机器人研发商 | 未公开 | 运营中
中国-浙江
2024-04-26
查看

(VCBeat) Aug. 09, 2021 -- Meio CadiNav Medical, a robotics company for interventional cardiovascular surgery, has closed on a Pre-Series A financing package. The proceeds will be used to build a cleanroom system compliant with GMP and promote clinical trials of the "Titian" robot for navigation in cardiac electrophysiology.


This round of financing is invested by TusStar, with Mingxi Capital acting as the exclusive financial advisor for the transaction.


Meio CadiNav Medical was founded in June 2018 by Dr. Chen Yuemeng and Professor Lu Caiyi, director of the Department of Cardiology, 301 Hospital. Meio CadiNav Medical is committed to the research and development of surgical navigation techniques and interventional surgical robots in the department of cardiology, as well as the development of magnetic navigation platform and consumable product for magnetically guiding in cardiac surgery. The company has established a research and development barrier based on its own intellectual property rights. It has obtained 27 patents and filed for 47 patent applications. It has self-developed the "Titian" robot and the "Raphaello" surgical robot – a flexible magnetic navigation stereopositioning and precision ablation system.


Meio CadiNav Medical is headquartered in Shaoxing, Zhejiang province, with core research and development centers in Shanghai, Hangzhou and Shaoxing. In the first half of 2021, Meio CadiNav Medical has successfully completed animal experiments of "Titian".


Since its inception, Meio CadiNav Medical has been committed to becoming a leader in Robotic cardiac surgery, developing intelligent cath lab surgical solutions, and winning recognition from society.


>>>>

About TusStar


Founded in 1999 and headquartered in Beijing, China, TusStar is an investment firm that integrates innovation services and building business platforms. The company has incubated over 5000 firms, among which are excellent companies, including 49 Diamond Companies, 45 Golden Seed Project companies, and 34 listed companies as well as great entrepreneurs including 81 leading talents from RecruitmentProgram of Global Experts, Overseas Talent Pooling Program, and High-end Leading Talent Pooling Program.

相关赛道 医疗机器人
注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。
推荐阅读

毛群安:倡导健康文明生活方式要医者先行

新华健康 2024-07-27 12:54

Science:在肝脏再生过程中,代谢不灵活性促进线粒体健康

生物谷 2024-07-27 12:13

Science:利用人类线粒体mRNA结构组揭示人类线粒体中的基因表达机制

生物谷 2024-07-27 12:13

Mailman

共发表文章3245篇

最近内容
查看更多
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

相关公司
查看更多

启迪之星

创业投资及孵化机构

立即沟通

梅奥心磁

心脏介入手术机器人研发商

立即沟通
产业链接
查看更多